Ipca Laboratories Limited (NSE:IPCALAB)

Ipca Laboratories Revenue

Ipca Laboratories had revenue of 29.10B INR in the quarter ending September 30, 2026, with 13.83% growth. This brings the company's total for the last twelve months to 104.80B, up 11.98% year-over-year. In the fiscal year ending March 31, 2026, Ipca Laboratories had annual revenue of 96.47B with 7.90% growth. That makes Ipca Laboratories the 7,149th largest company in the world by revenue and 268th in India.

• Revenue (ttm): 104.80B
• Revenue Growth: +11.98%
• P/S Ratio: 4.61
• Revenue / Employee: 6.09M
• Employees: 17,210
• Market Cap: 483.31B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• India 43.87B 45.5%
• Outside India (Excluding United Kingdom) 31.20B 32.3%
• USA 21.40B 22.2%

Fiscal year ended Mar 31, 2026 See the full Ipca Laboratories breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	96.47B	7.06B	7.90%
Mar 31, 2025	89.41B	12.35B	16.03%
Mar 31, 2024	77.06B	14.58B	23.33%
Mar 31, 2023	62.48B	4.18B	7.16%
Mar 31, 2022	58.31B	4.10B	7.56%

Data Source: S&P Global Market Intelligence Last updated: Nov 5, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error